HODGKIN DISEASE
Clinical trials for HODGKIN DISEASE explained in plain language.
Never miss a new study
Get alerted when new HODGKIN DISEASE trials appear
Sign up with your email to follow new studies for HODGKIN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental lymphoma drug enters first human tests
Disease control TerminatedThis early-stage study tested an experimental drug called PF-08046044/SGN-35C in 58 adults with advanced lymphomas (Hodgkin and non-Hodgkin types) who had no standard treatment options left. The main goals were to check safety, find the best dose, and see how the body handles the…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New lymphoma drug trial halted early after safety check
Disease control TerminatedThis early-stage study tested a new drug, PF-08046045, in 22 adults with advanced lymphomas that had not responded to other treatments. The goal was to find a safe dose and check for side effects. The study was terminated early, so results are limited.
Matched conditions: HODGKIN DISEASE
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 14, 2026 12:06 UTC